Pilot study of the eHealth application *Cancer Patients Better Life Experience*
Recruiting
- Conditions
- melanoma skincancer10040900
- Registration Number
- NL-OMON51454
- Lead Sponsor
- Antoni van Leeuwenhoek Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 36
Inclusion Criteria
In order to be eligible to participate in this study, a subject must meet all
of the following criteria:
* >18 years of age
* Sufficient understanding of the Dutch language
* Participants or their caregiver can use a smartphone (upon patient*s consent)
* Histologically confirmed melanoma (high-risk resectable stage III and stage
IV and unresectable stage III) patients indicated to receive treatment with
immune checkpoint-inhibitors, according to the clinical guidelines.
Exclusion Criteria
Included in experimental clinical trial (with medication)
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Main study parameters are the fatigue symptom scale of The European<br /><br>Organization for Research and Treatment of Cancer Quality of Life<br /><br>Questionnaire-core 30 (EORTC QLQ-C30). The EORTC QLQ-C30 is a self-reported<br /><br>questionnaire, specifically developed for patients with cancer who are<br /><br>receiving cancer treatment. The EORTC-QLQ- C30 is widely accepted and validated<br /><br>in clinical studies and is the most common quality of life instrument used in<br /><br>melanoma studies. </p><br>
- Secondary Outcome Measures
Name Time Method